Literature DB >> 17613708

Neonatal Borna disease virus infection in rats is associated with increased extracellular levels of glutamate and neurodegeneration in the striatum.

Mikhail V Ovanesov1, Michael W Vogel, Timothy H Moran, Mikhail V Pletnikov.   

Abstract

The authors evaluated a role of glutamate (GLU) excitotoxicity in neonatal Borna disease virus (BDV) infection-associated neuronal injury by measuring extracellular levels of GLU in the striatum of 70-day-old Fischer344 rats using in vivo microdialysis. The effects of BDV infection on the protein levels of the GLU transporters and the cystine-GLU antiporter and on the total numbers of striatal neurons and the volume of the striatum were also assessed. BDV increased the basal levels of GLU but did not change those of aspartate, glutamine, or taurine. BDV infection did not alter the effects of a blockade of GLU transporters but attenuated the effects of an inhibition of the cystine-GLU antiporter, without affecting the protein levels of the GLU transporters. The elevated levels of GLU were associated with decreased neuronal numbers and volume in the striatum. The present data are the first in vivo evidence that GLU excitotoxicity might contribute to BDV-associated neuronal injury in the striatum.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17613708     DOI: 10.1080/13550280701258415

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  40 in total

Review 1.  Interactions of viral proteins with neurotransmitter receptors may protect or destroy neurons.

Authors:  G Gosztonyi; H Ludwig
Journal:  Curr Top Microbiol Immunol       Date:  2001       Impact factor: 4.291

2.  Cytokine expression in the rat central nervous system following perinatal Borna disease virus infection.

Authors:  C Sauder; J C de la Torre
Journal:  J Neuroimmunol       Date:  1999-04-01       Impact factor: 3.478

3.  Bidirectional modulation of cystine/glutamate exchanger activity in cultured cortical astrocytes.

Authors:  Xing-Chun Tang; Peter W Kalivas
Journal:  Ann N Y Acad Sci       Date:  2003-11       Impact factor: 5.691

Review 4.  Extracellular level of GABA and Glu: in vivo microdialysis-HPLC measurements.

Authors:  Gabriella Nyitrai; Katalin A Kékesi; Gábor Juhász
Journal:  Curr Top Med Chem       Date:  2006       Impact factor: 3.295

5.  The origin and neuronal function of in vivo nonsynaptic glutamate.

Authors:  David A Baker; Zheng-Xiong Xi; Hui Shen; Chad J Swanson; Peter W Kalivas
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

Review 6.  Glutamate uptake.

Authors:  N C Danbolt
Journal:  Prog Neurobiol       Date:  2001-09       Impact factor: 11.685

Review 7.  Mechanisms of neuronal injury and death in HIV-1 associated dementia.

Authors:  Marcus Kaul; Stuart A Lipton
Journal:  Curr HIV Res       Date:  2006-07       Impact factor: 1.581

8.  An infection-based model of neurodevelopmental damage.

Authors:  M Hornig; H Weissenböck; N Horscroft; W I Lipkin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

Review 9.  Role of glutamate in neurodegeneration of dopamine neurons in several animal models of parkinsonism.

Authors:  P K Sonsalla; D S Albers; G D Zeevalk
Journal:  Amino Acids       Date:  1998       Impact factor: 3.520

Review 10.  Borna disease--neuropathology and pathogenesis.

Authors:  G Gosztonyi; H Ludwig
Journal:  Curr Top Microbiol Immunol       Date:  1995       Impact factor: 4.291

View more
  8 in total

1.  HCMV induces dysregulation of glutamate uptake and transporter expression in human fetal astrocytes.

Authors:  Li Zhang; Ling Li; Bin Wang; Dong-Meng Qian; Xu-Xia Song; Ming Hu
Journal:  Neurochem Res       Date:  2014-10-08       Impact factor: 3.996

Review 2.  The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder.

Authors:  Ke Wu; Gregory L Hanna; David R Rosenberg; Paul D Arnold
Journal:  Pharmacol Biochem Behav       Date:  2011-10-15       Impact factor: 3.533

3.  Borna disease virus infection perturbs energy metabolites and amino acids in cultured human oligodendroglia cells.

Authors:  Rongzhong Huang; Hongchang Gao; Liang Zhang; Jianmin Jia; Xia Liu; Peng Zheng; Lihua Ma; Wenjuan Li; Jing Deng; Xiao Wang; Liu Yang; Mingju Wang; Peng Xie
Journal:  PLoS One       Date:  2012-09-07       Impact factor: 3.240

4.  Central Nervous System Infection with Borna Disease Virus Causes Kynurenine Pathway Dysregulation and Neurotoxic Quinolinic Acid Production.

Authors:  Simone Formisano; Mady Hornig; Kavitha Yaddanapudi; Mansi Vasishtha; Loren H Parsons; Thomas Briese; W Ian Lipkin; Brent L Williams
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

5.  Activation of ERK/CREB/BDNF pathway involved in abnormal behavior of neonatally Borna virus-infected rats.

Authors:  Chenmeng Li; Xiaoyan Xu; Xiong Zhang; Ke Cheng; Yujie Guo; Jie Jie; Hua Guo; Yong He; Chanjuan Zhou; Siwen Gui; Xiaogang Zhong; Haiyang Wang; Peng Xie
Journal:  Neuropsychiatr Dis Treat       Date:  2018-11-15       Impact factor: 2.570

6.  GC-MS-Based Metabonomic Profiling Displayed Differing Effects of Borna Disease Virus Natural Strain Hu-H1 and Laboratory Strain V Infection in Rat Cortical Neurons.

Authors:  Siwen Liu; Liv Bode; Lujun Zhang; Peng He; Rongzhong Huang; Lin Sun; Shigang Chen; Hong Zhang; Yujie Guo; Jingjing Zhou; Yuying Fu; Dan Zhu; Peng Xie
Journal:  Int J Mol Sci       Date:  2015-08-17       Impact factor: 5.923

7.  Sero-epidemiological analysis of vertical transmission relative risk of Borna disease virus infection in dairy herds.

Authors:  Tatsuya Ando; Tadashi Takino; Kohei Makita; Motoshi Tajima; Masateru Koiwa; Katsuro Hagiwara
Journal:  J Vet Med Sci       Date:  2016-08-05       Impact factor: 1.267

8.  Glutamine antagonist-mediated immune suppression decreases pathology but delays virus clearance in mice during nonfatal alphavirus encephalomyelitis.

Authors:  Victoria K Baxter; Rebecca Glowinski; Alicia M Braxton; Michelle C Potter; Barbara S Slusher; Diane E Griffin
Journal:  Virology       Date:  2017-05-19       Impact factor: 3.513

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.